GSE57872 | GSM1395733 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_MGH29_D11 | glioblastoma [None] | patient id: MGH29; cell type: Glioblastoma; subtype: None |
GSE64016 | GSM1562573 | Illumina HiSeq 2500 | Homo sapiens | H1_Exp3.265 | single H1 hESC | cell type: human embryonic stem cells; passages: 30-35; treatment: not sorted |
GSE64016 | GSM1562838 | Illumina HiSeq 2500 | Homo sapiens | G2_Exp1.060 | single H1-Fucci cell sorted from G2-M phase of the cell cycle only | cell type: human embryonic stem cells; passages: 35-40; treatment: FACS sorted |
GSE66357 | GSM1620362 | Illumina NextSeq 500 | Homo sapiens | PS034_R2_0_321 | U87 human glioma cells | cell type: U87 human glioma cells |
GSE67835 | GSM1657906 | Illumina NextSeq 500 | Homo sapiens | healthy cortex cell 36 | hippocampus OPC | tissue: hippocampus; cell type: OPC; age: postnatal 54 years; c1 chip id: 1772078218; experiment_sample_name: AB_S8 |
GSE67835 | GSM1658162 | Illumina NextSeq 500 | Homo sapiens | healthy cortex cell 292 | cortex oligodendrocytes | tissue: cortex; cell type: oligodendrocytes; age: postnatal 21 years; c1 chip id: nochipID8; experiment_sample_name: AB_S7 |
GSE67980 | GSM1660154 | AB 5500xl Genetic Analyzer | Homo sapiens | Pr9.3.8 | lineage-confirmed PCa CTC CRPC enzalutamide-naive (Group A) | donor: Pr9; donor type: CRPC; enzalutamide: enzalutamide-naive (Group A) |
GSE69405 | GSM1702702 | Illumina HiSeq 2500 | Homo sapiens | LC-PT-45-Re_SC43 | PDX, LC-PT-45-Re | cell type: PDX |
GSE70580 | GSM1810657 | Illumina HiSeq 2000 | Homo sapiens | T75_P2_A7_ILC3 | Donor T75-tonsil innate lymphoid cell (ILC3) | tonsil donor: Donor T75; facs gating: ILC3; cell type: tonsil Innate lymphoid cells |
GSE70580 | GSM1810913 | Illumina HiSeq 2000 | Homo sapiens | T86_P1_F5_ILC3 | Donor T86-tonsil innate lymphoid cell (ILC3) | tonsil donor: Donor T86; facs gating: ILC3; cell type: tonsil Innate lymphoid cells |